Novel encapsulation technology for oral delivery
Freund Pharmatec
BAC BV and Life Technologies have launched a new range of affinity columns will ‘unlock’ high speed affinity HPLC for pharmaceutical processing.
The columns - which combine BAC’s CaptureSelect antibody-based affinity tech with Life’s Poros resins – are available in four different sizes and for a range of applications, including: human antibody analysis, detection and capture.
“The launch of these columns exemplifies the success of this strategic collaboration in making these media available to the wider research community in a short timeframe,” said Laurens Sierkstra, CEO of BAC, adding, “We look forward to developing additional innovative products in the future.”
BAC and Life Technologies have worked together on the development of industrial processing technologies since 2011.
